Target intelligence / Profile preview

Microbiome modulation via probiotic extract

Molecular classification
Other (not a single molecule, receptor, enzyme, or protein family)
01

Overview

"Microbiome modulation via probiotic extract" does not refer to a single molecular entity but rather describes an intervention strategy using preparations derived from beneficial microorganisms—commonly Lactobacillus, Bifidobacterium, Enterococcus species—to alter the composition and/or activity of the intestinal microbiota. These extracts can include live bacteria (probiotics), their metabolic products (post-biotics), or components thereof. The goal is to restore balance within the gut ecosystem to promote health benefits such as improved immune regulation, enhanced barrier integrity, reduced inflammation/infection risk, better metabolic outcomes, and even potential effects on brain function through the gut-brain axis. Mechanisms involve competitive exclusion of pathogens; production of antimicrobial substances; stimulation/modulation of host immune responses; strengthening epithelial barriers by upregulating tight-junction proteins; altering signaling pathways relevant to immunity and metabolism. This term is "not considered a canonical therapeutic target" like receptors or enzymes but represents an area/intervention strategy within translational medicine focused on manipulating complex microbial communities for therapeutic benefit[1][2][3]. Because this entry does not correspond to a discrete molecule/receptor/enzyme/transporter/etc., it should be flagged as incorrect if used where only canonical drug targets are appropriate.

Other names
Probiotic modulation of gut microbiotaProbiotic extract-mediated microbiome modulationModulation of gut microbiota by probiotics
02

Biological functions

Immune responseRegulation of intestinal barrier functionModulation of host metabolismMaintenance of gastrointestinal homeostasisInfluence on gut-brain axis signaling
03

Disease associations

Inflammation (e.g., inflammatory bowel disease)Metabolic disease (e.g., obesity, diabetes)Infection (prevention and mitigation)Cancer (potential preventive effects)Neurological/psychiatric disorders via the gut-brain axis
04

Safety considerations

Strain-specific safety concerns with certain probiotics in immunocompromised individuals or those with severe illness.Potential risk for bacteremia or sepsis from live bacteria in rare cases.Variability in efficacy and safety depending on host factors such as age, health status, geography

Beyond the preview

Go deeper on Microbiome modulation via probiotic extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microbiome modulation via probiotic extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call